GFPT2 was a key enzyme of the hexosamine biosynthesis pathway that was investigated to anticipate the biology of colorectal cancer cells via enhancing the glycosylation of p65 and activating the NF-κB pathway (Zhang et al., 2018). This evidence concerns the gene GFPT2 and colorectal cancer.